 Patents as Topic
"Patents as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exclusive legal rights or privileges applied to inventions, plants, etc.
| Descriptor ID |
D010330
|
| MeSH Number(s) |
I01.880.604.583.458.650 N03.706.535.518.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Patents as Topic".
Below are MeSH descriptors whose meaning is more specific than "Patents as Topic".
This graph shows the total number of publications written about "Patents as Topic" by people in this website by year, and whether "Patents as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2008 | 0 | 1 | 1 | | 2009 | 1 | 1 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 0 | 1 | 1 | | 2015 | 1 | 1 | 2 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Patents as Topic" by people in Profiles.
-
Feldman RC, Hyman DA, Price WN, Ratain MJ. Negative innovation: when patents are bad for patients. Nat Biotechnol. 2021 08; 39(8):914-916.
-
Youn H, Strumsky D, Bettencourt LM, Lobo J. Invention as a combinatorial process: evidence from US patents. J R Soc Interface. 2015 May 06; 12(106).
-
Conti RM, Padula WV, Larson RA. Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Ann Hematol. 2015 Apr; 94 Suppl 2:S249-57.
-
Epstein MS, Ehrenpreis ED, Kulkarni PM. Biosimilars: the need, the challenge, the future: the FDA perspective. Am J Gastroenterol. 2014 Dec; 109(12):1856-9.
-
Bettencourt LM, Trancik JE, Kaur J. Determinants of the pace of global innovation in energy technologies. PLoS One. 2013; 8(10):e67864.
-
Conti RM, Rosenthal MB, Polite BN, Bach PB, Shih YC. Infused chemotherapy use in the elderly after patent expiration. Am J Manag Care. 2012 May 01; 18(5):e173-8.
-
Alexander GC, O'Connor AB, Stafford RS. Enhancing prescription drug innovation and adoption. Ann Intern Med. 2011 Jun 21; 154(12):833-7, W-301.
-
Pierce BL, Carlson CS, Kuszler PC, Stanford JL, Austin MA. The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies. Genet Med. 2009 Mar; 11(3):202-9.
-
Tamari M, Harada M, Hirota T, Nakamura Y. Host molecular defense mechanisms against Chlamydophila pneumoniae and genetic studies of immune-response-related genes in asthma. Recent Pat Inflamm Allergy Drug Discov. 2009 Jan; 3(1):17-25.
-
Navari RM. Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities. Curr Opin Investig Drugs. 2008 Jul; 9(7):774-85.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|